Click here to create your personal news page. The news that appears on Celgene Corporation will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Shopping Categories

  1. 1. Digital Camera
  2. 2. LCD Monitor
  3. 3. Mobile Phone
  4. 4. LCD TV
  5. 5. Laptop Computer
  6. 6. Graphic Card
  7. 7. Smartphone
  8. 8. Fridge
  9. 9. Freezer
  10. 10. Vacuum Cleaner
  11. 11. Digital Camcorder
  12. 12. Processor
  13. 13. Washing Machine
  14. 14. Microwave
  15. 15. Coffee Maker & Expresso

Wikio Shopping

  1. 1. Baby & Nursery
  2. 2. Car/Motor Bike
  3. 3. Communication
  4. 4. Computers
  5. 5. Electronics
  6. 6. Entertainment
  7. 7. Fashion & Lingerie
  8. 8. Finance
  9. 9. Gifts & Gadgets
  10. 10. Health & Beauty
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Sport & Fitness
  14. 14. Travel
  15. 15. Video Games

Participate



Celgene Corporation



Sort by : relevance - date - popularity
+Vote!

Obama Pick: Buy (OSIR.org.in) Osiris Therapeutics (OSIR) - Bloggingstocks.com

Looking for stocks that should benefit now that Senator Obama is officially President-Elect Obama? Many investors believe that liberals negatively impact stock markets in general and that the only companies to benefit from a liberal adminstration are Source: www.bloggingstocks.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - ReutersNov 10 (Reuters) [...]

+Vote!

Celgene (CELG): Blockbuster potential?

Filed under: Newsletters , Stocks to Buy "The medical arena has long been my favorite sectors; perhaps the best opportunities within the medical sector will be with companies who provide life-saving products for the treatment of serious diseases," says Dave Dyer . In The Dave Dyer Newsletter , he explains, "That is why Celgene (NASDAQ: CELG ) is an excellent choice in this economy." Here's his look...

+Vote!

Refer to a friend - PR (OSIRonline.org) Inside

Rodman & Renshaw Annual Global Investment Conference - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and Source: www.pr-inside.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - ReutersNov 10 (Reuters) - Biotechnology giant Celgene [...]

+Vote!

Osiris Therapeutics to Present at the Rodman & Renshaw 10th Annual - PR Inside

2008-11-09 23:53:01 - Rodman & Renshaw Annual Global Investment Conference - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory Source: www.pr-inside.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - ReutersNov 10 (Reuters) - Biotechnology giant [...]

+Vote!

Celgene Corporation to Present at the Lazard Capital Markets 5th Annual Healthcare Conference

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the Lazard Capital Markets 5th Annual Healthcare Conference on Wednesday, November 19, 2008 at 9:30 a.m. EST will be

+Vote!

(Adds details; updates share movement) - Reuters (Www.OSIRonline.com)

Nov 10 (Reuters) - Biotechnology giant Celgene Corp (CELG.O: Quote , Profile , Research , Stock Buzz ) said it received approval from U.S. health regulators to start human testing of its experimental stem-cell therapy for the treatment of Crohn’s Source: www.reuters.com

+Vote!

OSIR.org.in - OSIRIS THERAPEUTICS INC (OSIR) Stock Research - Quotes, Charts, News

Hot Healthcare Stocks JMP Healthcare Focus Conference Achillion works on Hepatitis C Spectrum discusses 1st Oncology NDA Celgene seeks #1 Source: stocks.forbes.com OSIR | X PRIZE FoundationType Post Author Replies Last updated; No posts available. Source: www.googlelunarxprize.org www.OSIR.org.inCELEBRATING EGYPT TODAY S 25th anniversary last month brought back memories of the days when poor Egyptian...

+Vote!

Reportlinker: Celgene Corporation Company Profile Just Released: Reported Sales and Forecasts, Market shares, R&D and New Product Development

NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.

+Vote!

(Adds details; (OSIR.org.in) updates share movement) - Reuters

Nov 10 (Reuters) - Biotechnology giant Celgene Corp (CELG.O: Quote , Profile , Research , Stock Buzz ) said it received approval from U.S. health regulators to start human testing of its experimental stem-cell therapy for the treatment of Crohn’s Source: www.reuters.com Refer to a friend - PR InsideRodman & Renshaw Annual Global Investment [...]

+Vote!

Www.OSIR.org.in - Health Winners & Losers: Amgen - Street.Com

Health stocks lagged Thursday but fared better than the broader market, with the Nasdaq and Amex biotechnology indices down 1.6% and 1.7%, respectively. Among individual stocks, notable movers were: Simcere ( SCR Quote - Cramer on SCR - Stock Picks Source: www.thestreet.com UPDATE 1-Celgene stem cell therapy gets FDA nod for human trials - [...]

+Vote!

Celgene Wins FDA Clearance for Phase I Placenta-Derived Stem Cell Study

Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, has announced that the FDA has accepted the company's investigational new drug application to initiate a clinical trial using PDA001, an immunomodulatory therapy utilizing human placenta-derived stem cells obtained via the company's proprietary processes.

+Vote!

128 Abstracts Evaluating Celgene Products to Be Presented at the 50th Annual American Society of Hematology Meeting

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced that clinical investigators from leading hematology research

+Vote!

Celgene Corporation to Present at the 2008 Credit Suisse Annual Health Care Conference

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 2008 Credit Suisse Annual Health Care Conference on Wednesday, November 12,

+Vote!

The Biotech Triumvirate

Celgene, Gilead and Amgen are the three biotech leaders of the Nasdaq.

+Vote!

TheCramerReport.com#39;s bMad Money/b Recap - November 3, 2008

Also, ag and fertilizer stocks could profit from Obama pushing ethanol. Cramer added that Celgene (CELG) and Gilead (GILD)… Visit The Cramer Report to read the rest of the bMad Money/b recap and get the rest of Jim Cramer’s investing b…/b Source:TheCramerReport.com#39;s bMad Money/b Recap - November 3, 2008